Evaluation of Early Endovascular Treatment in Acute Ischemic Stroke With Isolated Internal Carotid Artery Occlusion (EVT-iICAO)

Status: Recruiting
Location: See location...
Intervention Type: Drug, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The primary hypothesis being tested in this trial is that acute ischemic stroke with isolated internal carotid artery occlusion will have improved clinical outcomes when given early endovascular treatment compared with that of given best medical treatment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18.

• Clinical signs consistent with an acute ischemic stroke and randomization no later than 23 hours after the time last known to be well.

• CTP, CTA or enhanced MRA within 1 hour before randomization showed that the offending vessel was isolated internal carotid artery occlusion, namely occlusion of C1-C6 segments (according to Bouthillier's segmentation) at any location. There was no ipsilateral intracranial branch occlusion (T or L shape of internal carotid artery, M1 or M2 segment of middle cerebral artery, A1 or A2 segment of anterior cerebral artery, P1 or P2 segment of posterior cerebral artery).

• Neurological deficit with a NIHSS of \>5, or ≤5 points with disabling symptoms (complete hemianopsia, severe aphasia, neglect, any limb weakness that cannot sustain resistance to gravity, and functional loss that is considered by doctors and patients to be potentially disabling by clinical evaluation).

• Mismatch: target Mismatch Profile on CT perfusion or MRI (ischemic core volume is \< 70 ml, mismatch ratio is ≥1.8 and mismatch volume is ≥15 ml); clinical-imaging mismatch defined as an ASPECTS score of more than 5, was present if perfusion data were not available or imaging quality was poor enough to be interpreted.

• mRS Score before stroke ≤2.

• Patient/Legally Authorized Representative has signed the Informed Consent form.

Locations
Other Locations
China
Sir Run Run Shaw Hospital
RECRUITING
Hangzhou
Time Frame
Start Date: 2025-06
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 140
Treatments
Experimental: Endovascular treatment plus the best medical treatment
Active_comparator: The best medical treatment
Related Therapeutic Areas
Sponsors
Leads: Sir Run Run Shaw Hospital

This content was sourced from clinicaltrials.gov